VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. - Wikidata - awgldk - TriplyDB

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

http://www.wikidata.org/entity/Q37587264

about

Rate of entropy model for irreversible processes in living systems.

P2860

Q38638557-4E3D2D61-2C70-4C97-8F61-7745A9CE6DA8

P2860

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

http://www.wikidata.org/entity/Q37587264

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@en

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@nl

type

label

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@en

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@nl

prefLabel

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@en

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@nl

P1433

Q37587264-6DD1C15A-6911-4EFA-8B01-2397FA364CBE

P1476

Q37587264-82171601-A975-4792-BDC6-F007F9E72B38

P2093

Q37587264-10D83AAA-1C06-4C97-B163-FCDAA1D47657

Q37587264-26CC7EF9-44A2-4E53-AFA8-1692AD5A11D5

Q37587264-34356AD0-DE55-4090-B6A4-EB61088C4B99

Q37587264-4317B366-B12E-4467-98DB-07796E521459

Q37587264-57C10D0D-7788-47BF-8EB6-EF67C3D84829

Q37587264-8155373F-1B7D-489C-835D-5F9B01F1B8A4

Q37587264-8ACC854A-568F-48C5-945D-86AF0294BF1F

Q37587264-95A75F55-76E8-4778-A1DF-0CDFDE0B79BB

Q37587264-A7353459-607B-4438-BED8-01D8FF09FA40

Q37587264-C8705242-2C6B-4E5F-AD08-65EEA6EB737F

P2860

Q37587264-04E3D97A-1A75-470D-899C-2BB40D5BE509

Q37587264-05EBFF80-74F1-4E81-B09B-D10E1629701E

Q37587264-0B93514B-FDBA-47C0-971E-C5590DE9F9AF

Q37587264-1C2F3BA2-5FC4-4058-A9B3-1A11FFC8FDB8

Q37587264-213E422D-2B7A-4B38-A45E-2B451564E626

Q37587264-21BF2E21-DABA-44F5-B3FD-9B5754ABA4C7

Q37587264-243B3760-75BD-4F9B-8C8D-A747F93F9F11

Q37587264-24C184DA-3501-429C-8FEC-945E68582E46

Q37587264-263AA5C7-3237-404F-87EC-31F807326D1E

Q37587264-2A0317A7-9DB1-4388-B342-9481B6656B0D

P2888

Q37587264-DAB0916A-2025-46F2-9143-A5F5FED5BD06

P304

Q37587264-3E96FAF9-7BC6-4DB4-AF79-936EB3485187

P31

Q37587264-2A4E533D-BE2A-4912-BA4C-EDB64B403E88

P356

Q37587264-2300A615-965E-4B1D-A719-7D179B19297B

P407

Q37587264-8614586A-0D85-4B7F-8897-182FDDEAD46A

P433

Q37587264-2CBFDA90-CA56-4BC2-9DB1-3D1B87E2BF34

P478

Q37587264-3AEF4638-745B-41A2-B29B-587F72E84A4F

P50

Q37587264-0C849F50-2F00-4506-911E-AF392E4FA659

Q37587264-830210FC-98E6-4A77-BB8E-38DDC21EAEFB

Q37587264-E5D7CFE3-EE1A-4BD3-9A5D-823A79E0751B

P577

Q37587264-90032285-7563-4303-8241-55D71D4F37FE

P698

Q37587264-C5809CA4-DD21-4A50-A168-CD83D64D17C1

P921

Q37587264-BAA25F13-A98E-48E3-B4B7-8C58E1632008

P932

Q37587264-B35C486E-591F-4BEB-BF3C-6EFE7E7278B5

P356

P1433

P1476

VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors.

@en

P2093

A Rosenwald

http://www.w3.org/2001/XMLSchema#string

D A Scheinberg

http://www.w3.org/2001/XMLSchema#string

H Hoffmann

http://www.w3.org/2001/XMLSchema#string

I Weigand

http://www.w3.org/2001/XMLSchema#string

K Manova

http://www.w3.org/2001/XMLSchema#string

M Tenspolde

http://www.w3.org/2001/XMLSchema#string

M Wartenberg

http://www.w3.org/2001/XMLSchema#string

O Penack

http://www.w3.org/2001/XMLSchema#string

S Ergün

http://www.w3.org/2001/XMLSchema#string

S Gätzner

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo inhibition of lysyl oxidase by aminopropionitriles

Lysyl oxidase: a lung adenocarcinoma biomarker of invasion and survival

Lysyl oxidase is essential for hypoxia-induced metastasis

Lysyl oxidase mediates hypoxic control of metastasis

Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.

The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells

Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF.

P2888

P304

1-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2016.182

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

Freddy E Escorcia

Florian Röhrig

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27270432

http://www.w3.org/2001/XMLSchema#string

P921

P932

5237662

http://www.w3.org/2001/XMLSchema#string